study ciliary dyskinesia factor cystic fibrosis iv possible identification anaphylatoxin c3aigg complex presumptive evidence indicates substance responsible pathophysiologic condition cystic fibrosis cf complement component c3a also known anaphylatoxin known biochemical physiological property c3a together behavior purified substance associated igg tracheal bioassay compare favorably molecular specie separated serum cell culture cf homozygote heterozygote serum normal healthy subject previously inactive bioassay ciliary dyskinesia factor cdf converted cdf positive state incubation epsilonaminocaproicacid eaca eaca known inhibitor carboxypeptidaseblike anaphylatoxin inactivator method choice accumulating anaphylatoxins normal blood incubation eacatreated normal serum two fresh cdfpositive cf serum carboxypeptidaseb produced reversion instance cdf negative normal state proposed anaphylatoxin inactivator carboxypeptidaseblike enzyme defective deficientin cystic fibrosis deficiency primary gene defect